Searchable abstracts of presentations at key conferences in endocrinology

ea0037oc10.4 | Nuclear receptors and signalling | ECE2015

An autoregulatory loop of nuclear corepressor 1 expression controls hepatocarcinoma invasion, growth and metastasis

Martinez-Iglesias Olaia , Alonso-Merino Elvira , Velasco-Martin Juan P , Martin-Orozco Rosa M , Luengo Enrique , Garcia-Martin Rosa M , de Caceres Inmaculada Ibanez , Fernandez Agustin F , Fraga Mario , Gonzalez-Peramato Pilar , Varona Constantino , Palacios Jose , Regadera Javier , Aranda Ana

Nuclear corepressor 1 (NCoR) associates with nuclear receptors and other transcription factors leading to transcriptional repression. Genomic studies have shown the presence of inactivating mutations of the NCoR gene in human tumours and we have found that NCoR depletion with siRNA in hepatocarcinoma SK-hep1 cells enhances invasion, tumour growth and metastasis in nude mice, while expression of the thyroid hormone receptor β (TRβ) increases NCoR levels, repr...

ea0014p168 | (1) | ECE2007

Somatostatin receptor immunohistochemistry in neuroendocrine tumors: a proposal of scoring system for clinical characterization and therapy selection

Faggiano Antongiulio , Volante Marco , Pia Brizzi Maria , La Rosa Stefano , Rapa Ida , Ferrero Anna , De Chiara Anna , Righi Luisella , Capella Carlo , De Rosa Gaetano , Dogliotti Luigi , Colao Annamaria , Papotti Mauro

Background: Typing somatostatin receptor (SSTR) expression in neuroendocrine tumors (NETs) is of relevance to target an octreotide-based diagnostic approach and treatment. The expanding use of immunohistochemistry to detect SSTR is to date not paralleled by an accurate methodological setting and standardized interpretation of the results.Objective: A multicentric study was designed to compare SSTR immunohistochemical expression with in vivo scinti...

ea0081p662 | Pituitary and Neuroendocrinology | ECE2022

Inferior petrosal sinus sampling for pituitary neuroendocrine tumors localization in cushing’s disease

Moreno-Moreno Paloma , Rosa Alhambra Exposito Ma , Rebollo-Roman Angel , Herrera-Martinez Aura D. , Angeles Galvez-Moreno Maria

Objective: Cushing’s disease (CD) is the most common cause of hypercortisolism after iatrogenic origin, it represents approximately 70% of patients with endogenous Cushing’s syndrome (CS) and ectopic ACTH secretion (10%). CD is caused by a corticotropin-secreting pituitary neuroendocrine tumor (ACTH-secreting Pit-NETs), 95% of cases as a microadenoma. In ACTH-dependent CS, differential diagnosis between CD and ectopic CS must be established. 40% of CD cases, any tumo...

ea0081ep569 | Endocrine-Related Cancer | ECE2022

Novel pathogenetic mutation of MEN1 gene causing hyperparathyroidism, pancreatic glucagonoma, adrenal adenoma, and collagenomas

Pitino Rosa , Vimercati Davide , Pizzolitto Francesca , Mollero Edoardo Luigi Maria , Daffara Tommaso , Ferrero Alice , Boldorini Renzo , Caputo Marina , Prodam Flavia

Background: Multiple endocrine neoplasia type 1 (MEN1) is a rare hereditary autosomal dominant tumor syndrome caused by inactivating mutations of the tumor suppressor gene MEN1 which encodes the protein menin. It is characterized by the occurrence of tumors involving two or more endocrine glands, primarily parathyroid, entero-pancreatic, and anterior pituitary, as well as non-endocrine neoplasms. Glucagonomas occur in fewer than 3% of patients with MEN1, causing hyper...

ea0084ps2-06-49 | Hypothyroidism Treatment | ETA2022

Faecal microbiota composition in patients with increased need of levothyroxine

Virili Camilla , Filardo Simone , Stramazzo Ilaria , Capriello Silvia , Giulia Santaguida Maria , Gargano Lucilla , Sessa Rosa , Centanni Marco

Objectives: Variations of gut microbiota composition have been described in patients with different thyroid disorders. The site of oral levothyroxine (T4) absorption is represented by the small intestine and it has been demonstrated that some bacterial strains possess enzymatic activity that may affect iodothyronine deconjugation, process probably involved in thyroid hormone enterohepatic recycling. The relationship between gut microflora composition and oral T4 requirement ha...

ea0090rc7.4 | Rapid Communications 7: Pituitary and Neuroendocrinology 2 | ECE2023

Effects of prolactin excess and treatment with cabergoline on bone mineral density and fracture risk in men

Del Vecchio Guendalina , Sorice Federica , Scairati Roberta , Pirchio Rosa , Meglio Sara Di , Pivonello Rosario , Colao Annamaria , Aurie mma Renata Simona

Purpose: The present study aims to investigate the effects of hyperprolactinemia (HPRL) and its pharmacological control with Cabergoline (CAB) on the risk of fractures in male patients affected by prolactinoma.Methods: Observational single-center study was conducted on 39 male patients (median age 49±12,4 y) with prolactinoma, including 37 with macroprolactinoma and 2 with empty sellae. In patients PRL levels at diagnosis (PRL 0’), PRL at evalu...

ea0090p413 | Pituitary and Neuroendocrinology | ECE2023

Sleep Disorders And Osas Risk in Patients with Prolactinoma: A Single Center Experience

Del Vecchio Guendalina , Sorice Federica , Scairati Roberta , Pirchio Rosa , Di Meglio Sara , Pivonello Rosario , Colao Annamaria , Simona Auriemma Renata

Purpose: Dopaminergic system is implicated in the development of sleep disorders, and dopaminergic agents are used in clinical practice to treat daytime sleepiness and sleep disorders. The present study aimed at investigating the effects of hyperprolactinemia and its control with dopamine-agonists (DA) on sleep quality, excessive daytime sleepiness (ESS) and risk of obstructive sleep apnea syndrome (OSAS) in prolactinomas.Methods: A single-centre study w...

ea0090ep1123 | Late Breaking | ECE2023

Trends in Prescription of Anti-Diabetic Drugs and Metabolic Control in Type 2 Diabetes: 2015/2016 vs. 2020/2021

Soares Daniela , Palma Isabel , Helena Neto Maria , Fraga Mariana , Pereira Joel , Guimaraes Rosa , Helena Cardoso Maria , Maia Ariana , Ferreira Lia

Introduction: The development of new pharmacological classes for type 2 diabetes (T2D) treatment with extra-glycaemic benefits has led to the update of the treatment algorithm, presenting new effective alternatives to patients’ insulinization. The present study aims to evaluate the evolution of prescription and its impact in metabolic control of patients enrolled on an educational diabetes program of a tertiary hospital.Objectives: To evaluate trend...

ea0063oc1.3 | Calcium and Bone | ECE2019

Menin and EZH2 activities modulate the expression of the long non-coding RNA HAR1B in parathyroid tumors

Morotti Annamaria , Verdelli Chiara , Guarnieri Vito , Muscarella Lucia Anna , Silipigni Rosa , Guerneri Silvana , Vicentini Leonardo , Vaira Valentina , Corbetta Sabrina

Epigenetic deregulation is emerging as a component of the parathyroid tumorigenesis. We identified a long non-coding RNA (LNCRNA) signature clearly distinguishing parathyroid adenomas (PAds) and carcinomas from normal glands. Among the deregulated LncRNAS, HAR1B was upregulated in PAds harboring the common chromosome 11q loss of heterozygosity (Chr11q-LOH; n=10) compared with PAds harboring normal chromosome 11 haplotype (Chr11q-WT; n=12; P&...

ea0063gp95 | Adrenal and Neuroendocrine - Basic | ECE2019

The role of filamin A (FLNA) in the regulation of IGF2/IGF1R pathway in adrenocortical carcinomas

Peverelli Erika , Catalano Rosa , Giardino Elena , Mangili Federica , Treppiedi Donatella , Morelli Valentina , Mannelli Massimo , Spada Anna , Arosio Maura , Mantovani Giovanna

Adrenocortical carcinomas (ACCs) are rare endocrine tumors with poor prognosis. The insulin-like growth factor 2 (IGF2) is overexpressed in the great majority of ACC, and IGF2/IGF1R pathway acts as a proliferative autocrine loop, but to date IGF1R-targeted therapies have demonstrated a limited efficacy and the molecular mechanisms regulating this pathway are still unknown. The cytoskeleton acting-binding protein filamin A (FLNA), determinant in cancer progression and metastasi...